ArticleMolecular cancer2023

Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.

Ji Eun Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.